COVID-19 archives
2023
- Recommendation on Covid-19 booster vaccination for autumn 2023 (Pdf, 863 Kb) (CSMI recommendation dated 26 September 2023)
- Recommendation on a second COVID-19 booster dose (Pdf, 994 Kb) (CSMI updated recommendation of 6 March 2023)
- Recommendation on first-time vaccination with bivalent COVID-19 vaccines (Pdf, 724 Kb) (CSMI recommendation dated 27 February 2023)
2022
- CSMI recommendations on COVID-19 vaccination of children aged six months to five years (Pdf, 1.12 Mb) (CSMI recommendation dated 29 November 2022)
- CSMI recommendation on COVID-19 and pregnancy (Pdf, 763 Kb) (CSMI recommendation dated 19 October 2022)
- Recommendation on a fourth COVID-19 vaccine dose for individuals aged 60 and over (Pdf, 868 Kb) (CSMI recommendation dated 14/07/2022)
- Recommendation on a fourth COVID-19 vaccine dose (Pdf, 666 Kb) (CSMI recommendation dated 12/04/2022)
- COVID-19 vaccination of pregnant and breastfeeding women (Pdf, 712 Kb) (CSMI recommendation dated 21 March 2022)
- COVID-19 patients (Pdf, 683 Kb) (infected with SARS-CoV-2: duration of isolation (CSMI recommendation dated 21 March 2022)
- Resumption of the COVID-19 vaccination plan (French, Pdf, 694 Kb) following interruption (CSMI recommendation dated 3 March 2022)
- Shortening the interval between first-time COVID-19 vaccination and the booster vaccination (Pdf, 729 Kb) (update of 3 March 2022)
- Novavax NuvaxovidR COVID-19 vaccine (Pdf, 748 Kb)(CSMI recommendation dated 25 February 2022)
- COVID-19 vaccination (Pdf, 820 Kb) of children aged five to eleven years (update of 6 January 2022)
2021
- Recommendation (Pdf, 773 Kb) on SARS-CoV-2 booster vaccination following first-time vaccination (CSMI recommendation dated 14 December 2021)
- COVID-19 vaccination (Pdf, 778 Kb) of children aged five to eleven years (CSMI recommendation dated 29 November 2021)
- Recommendations (Pdf, 769 Kb) on SARS-CoV-2 booster vaccination following first-time vaccination (CSMI recommendation dated 9 November 2021)
- Optimal dose of messenger RNA vaccine (Pdf, 703 Kb) following COVID-19 vaccination with the Janssen vaccine (CSMI recommendation dated 14 October 2021)
- Simultaneous administration (Pdf, 774 Kb) of COVID-19 and seasonal influenza vaccines (CSMI opinion dated 7 October 2021)
- Screening (Pdf, 717 Kb) in facilities providing medical and social care services, and in homes for the elderly providing medical and social care services (CSMI recommendation dated 18 August 2021)
- Second COVID-19 vaccine dose (Pdf, 730 Kb) for persons with a contraindication to the Vaxzevria vaccine (CSMI recommendation dated 08/07/2021)
- Third COVID-19 vaccine dose (Pdf, 713 Kb) in immunosuppressed individuals (recommendation dated 02/07/2021)
- Second COVID-19 vaccine dose (Pdf, 709 Kb) for persons with a contraindication to the Vaxzevria vaccine (CSMI recommendation dated 18 June 2021)
- Vaccination (Pdf, 719 Kb) following COVID-19 infection (CSMI recommendation dated 10 June 2021, corrected on 16 June 2021)
- COVID-19 vaccination (Pdf, 849 Kb) of young people aged 12 to 18 years (update of 17 August 2021)
- Johnson&Johnson's JCOVDEN COVID-19 vaccine (Pdf, 744 Kb) (CSMI opinion dated 30 April 2021)
- Thrombocytopenia and thrombosis (Pdf, 4.41 Mb) following COVID-19 vaccination (CSMI recommendation dated 23 April 2021)
- Thromboembolic risks (Pdf, 974 Kb) following COVID-19 vaccination (CSMI opinion dated 16 April 2021)
- COVID 19 vaccination strategy (Pdf, 759 Kb) in Luxembourg – phase 2 and subsequent phases (update of 29 March 2021)
- AstraZeneca COVID-19 vaccine (Pdf, 777 Kb) (update of 02/03/2021)
- Comirnaty COVID-19 vaccine (Pdf, 714 Kb) (CSMI recommendation dated 15/01/2021)
- AstraZeneca COVID-19 vaccine (Pdf, 639 Kb) (update of 16/02/2021)
- AstraZeneca COVID-19 vaccine (Pdf, 806 Kb) (CSMI recommendation dated 04/02/2021)
- COVID 19 vaccination strategy (Pdf, 759 Kb) in Luxembourg – Phase 2 and subsequent phases (CSMI opinion dated 28/01/2021)
- Moderna COVID-19 vaccine (Pdf, 878 Kb) (CSMI recommendation dated 20/01/2021)
- Wearing facemasks (Pdf, 702 Kb) in class (CSMI recommendation dated 6 January 2021)
- Comirnaty COVID-19 vaccine (Pdf, 802 Kb) (CSMI recommendation dated 6 January 2021)
- Communication on pubic health measures (Pdf, 647 Kb) (CSMI communication dated 5 January 2021)
2020
- Communication on pubic health measures (Pdf, 525 Kb) (CSMI communication dated 16 December 2020)
- Use of antigen tests (Pdf, 869 Kb) to detect the SARS-CoV-2 virus (CSMI recommendation dated 29 October 2020)
- COVID-19 and pregnancy (Pdf, 716 Kb) (CSMI recommendation dated 1 October 2020)
- COVID-19 strategy (Pdf, 692 Kb) and children under the age of four (CSMI recommendation dated 21 September 2020)
- COVID-19 vaccination strategy (Pdf, 676 Kb) (CSMI recommendation dated 22/09/2020)
- Protocol for managing patients (Pdf, 3.33 Mb) with confirmed or suspected COVID-19 infection (CSMI recommendation dated 02/04/2020)
- Persons with a high risk (Pdf, 671 Kb) of COVID-19 (CSMI recommendation dated 25 April 2020)
- Children with a high risk (Pdf, 669 Kb) of COVID-19 (CSMI recommendation dated 25 April 2020)
Last update